Adagio Medical Holdings, Inc.
ADGM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0002006986
No open-market purchases or sales by Adagio Medical Holdings, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $9.83M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Adagio Medical Holdings, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- 0 vs. Q4 2024
- Shares held
- 11.6M
- +791.4K (+7.3%) vs. Q4 2024
- Total value
- $9.33M
- −$2.01M (−17.7%) vs. Q4 2024
- New holders
- 3
- 4 more added
- Sold out
- 3
- 2 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $9.83M |
| Q1 2026 | 23 | $17.7M |
| Q4 2025 | 21 | $17.2M |
| Q3 2025 | 15 | $22.6M |
| Q2 2025 | 12 | $14.9M |
| Q1 2025 | 15 | $9.33M |
| Q4 2024 | 15 | $11.3M |
| Q3 2024 | 12 | $31.0M |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Adagio Medical Holdings, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 9,812,419 | $7.90M | 0.28% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 700,000 | $563.4K | 0.00% | +700,000 | New |
| Shaolin Capital Management LLC | 260,000 | $209.3K | 0.01% | +62,500+31.6% | Added |
| Affinity Asset Advisors, LLC | 213,235 | $169.5K | 0.03% | 00.0% | Unchanged |
| RTW Investments, LP | 209,361 | $168.5K | 0.00% | 00.0% | Unchanged |
| Opaleye Management Inc. | 110,571 | $92.1K | 0.02% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 100,000 | $79.5K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 76,757 | $61.8K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 36,799 | $29.3K | 0.00% | +14,047+61.7% | Added |
| Toronto Dominion Bank | 30,875 | $24.5K | 0.00% | +10,875+54.4% | Added |
| Citadel Advisors LLC | 28,877 | $23.0K | 0.00% | +28,877 | New |
| XTX Topco Ltd | 11,435 | $9.09K | 0.00% | −9,745−46.0% | Reduced |
| Tower Research Capital LLC (TRC) | 2,670 | $2.15K | 0.00% | −1,784−40.1% | Reduced |
| Barclays PLC | 197 | $159 | 0.00% | +197 | New |
| Bank of America Corp | 32 | $26 | 0.00% | +3+10.3% | Added |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,120−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,409−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −10−100.0% | Sold out |